BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,032.38
      0.56%
      US Tech 100
      20,389.60
      0.88%
      Dow Jones
      44,910.65
      0.42%
      Brent Oil
      71.98
      -0.08%
      Bitcoin
      96,363.78
      -1.15%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Dare Bioscience Inc (DARE) Quote

      Dare Bioscience Inc

      Dare Bioscience Inc (DARE)

      NASDAQ
      3.41
      0.11
      (3.33%)
      Closed November 30 4:00PM
      Delayed by 15 minutes
      3.41
      0.00
      (0.00%)
      After Hours: 4:55PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.41
      Bid
      3.18
      Ask
      3.56
      Volume
      26,341
      3.29 Day's Range 3.5057
      3.05 52 Week Range 7.56
      Market Cap
      29.668M
      Previous Close
      3.30
      Open
      3.31
      Last Trade
      1
      @
      3.3
      Last Trade Time
      Financial Volume
      $ 87,765
      VWAP
      3.3319
      Average Volume (3m)
      40,915
      Shares Outstanding
      8,700,389
      Dividend Yield
      -
      PE Ratio
      -0.98
      Earnings Per Share (EPS)
      -3.47
      Revenue
      2.81M
      Net Profit
      -30.16M

      About Dare Bioscience Inc

      Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve... Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.darebioscience.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Dare Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DARE. The last closing price for Dare Bioscience was $3.30. Over the last year, Dare Bioscience shares have traded in a share price range of $ 3.05 to $ 7.56.

      Dare Bioscience currently has 8,700,389 shares outstanding. The market capitalization of Dare Bioscience is $28.71 million. Dare Bioscience has a price to earnings ratio (PE ratio) of -0.98.

      Ask ADVFN Intelligence (AI)

      DARE Latest News

      More News

      Form EFFECT - Notice of Effectiveness

      November 27 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      November 26 2024
      Edgar (US Regulatory)

      Form D - Notice of Exempt Offering of Securities

      November 22 2024
      Edgar (US Regulatory)

      Form S-1 - General form for registration of securities under the Securities Act of 1933

      November 15 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 14 2024
      Edgar (US Regulatory)

      Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update

      Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate – pivotal Phase 3...

      November 14 2024
      GlobeNewswire Inc.

      Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites

      - Grant funds will support activities that will aid in the identification and development of a novel non-hormonal intravaginal contraceptive product candidate. - Grant will also provide funding...

      November 13 2024
      GlobeNewswire Inc.

      Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024

      SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, will host a conference call and live webcast at...

      November 07 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 25 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.185.572755417963.233.423.18329883.26204696CS
      4-0.87-20.32710280374.284.63.18543963.65903677CS
      12-0.02-0.5830903790093.434.63.18409153.58178764CS
      26-1.39-28.95833333334.86.243.051108054.57270974CS
      52-0.79-18.80952380954.27.563.053900354.42737552CS
      156-18.538-84.463276836221.94830.123.0589588617.46002513CS
      260-5.8312-63.10003029919.241246.23.05148400019.7495563CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BSLKBolt Projects Holdings Inc
      $ 0.71
      (139.86%)
      		80.07M
      PRZOParaZero Technologies Ltd
      $ 1.24
      (94.14%)
      		202.48M
      AIEVThunder Power Holdings Inc
      $ 0.47
      (87.25%)
      		122.71M
      PASGPassage Bio Inc
      $ 1.13
      (69.52%)
      		15.43M
      EPOWSunrise New Energy Company Ltd
      $ 1.06
      (45.21%)
      		314.9k
      APLTApplied Therapeutics Inc
      $ 2.03
      (-76.31%)
      		42.74M
      TGLTreasure Global Inc
      $ 0.2944
      (-29.08%)
      		1.83M
      PROCProcaps Group SA
      $ 1.51
      (-27.75%)
      		98.71k
      SHOTWSafety Shot Inc
      $ 0.104
      (-20.00%)
      		1.43k
      MONDMondee Holdings Inc
      $ 0.7102
      (-19.59%)
      		297.61k
      PRZOParaZero Technologies Ltd
      $ 1.24
      (94.14%)
      		205.02M
      NVDANVIDIA Corporation
      $ 138.25
      (2.15%)
      		141.86M
      AIEVThunder Power Holdings Inc
      $ 0.47
      (87.25%)
      		122.71M
      RGTIRigetti Computing Inc
      $ 3.05
      (27.08%)
      		116.98M
      MARAMARA Holdings Inc
      $ 27.42
      (1.86%)
      		89.54M

      DARE Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      DARE under $4
      👍️0
      powerbattles powerbattles 7 months ago
      $DARE took the starter! Secure $22 million in the non-dilutive & phase 2 and phase 3 coming $$$
      👍️0
      harry crumb harry crumb 7 months ago
      Wouldn’t touch this turd with monopoly money until after the r/s, an after the shorting!
      👍️0
      Awl416 Awl416 7 months ago
      Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
      👍️0
      willlbone willlbone 7 months ago
      Vote on R/S.
      👍️0
      glenn1919 glenn1919 9 months ago
      DARE.................................................https://stockcharts.com/h-sc/ui?s=DARE&p=W&b=5&g=0&id=p86431144783
      👍️0
      starkd748 starkd748 12 months ago
      It's dead lol
      👍️0
      Monksdream Monksdream 12 months ago
      DARE new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      DARE new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      DARE new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      DARE newb52 week low
      👍️0
      harry crumb harry crumb 2 years ago
      Might be a runner in due time
      👍️0
      nonsequetor nonsequetor 2 years ago
      The DARE train has not even left the station... gathering up steam...
      👍️0
      harry crumb harry crumb 2 years ago
      1.00 average, 100k
      👍️0
      nonsequetor nonsequetor 2 years ago
      I hope everyone loaded up Monday...
      👍️0
      nonsequetor nonsequetor 2 years ago
      Monday, Jan 23, is the day...
      👍️0
      harry crumb harry crumb 2 years ago
      Yep agree
      👍️0
      nonsequetor nonsequetor 2 years ago
      If Ovaprene is approved by the FDA, it could be the first monthly non-hormonal contraceptive product for women and a first-in-category option for women seeking a hormone-free, self-administered and monthly birth control method.

      https://www.biospace.com/article/releases/dare-bioscience-announces-ide-approval-for-a-single-arm-open-label-pivotal-contraceptive-efficacy-study-of-ovaprene-an-investigational-hormone-free-monthly-intravaginal-contraceptive/
      👍️0
      nonsequetor nonsequetor 2 years ago
      DARE starts revenue soon with its first approved drug, Xaciato and its licensing partner OGN. Q1 or Q2. Milestone payments and double digit royalties.

      Additionally, they have up to three products entering Ph3 trials this year: Ovaprene, Sildenafil and HRT-1. Ovaprene for sure is entering Ph3 this summer with NIH and licensing partner $BAYRY.

      By 2024, they could have FDA-approved products and $4-$5B market share and exclusivity.
      👍️0
      nonsequetor nonsequetor 2 years ago
      DARE Since Post:
      $0.3266
      (38.27%)
      Then:$0.8534
      Now:$1.18

      Nice chunk of change so far...
      👍️0
      harry crumb harry crumb 2 years ago
      Mayb, mayb not
      👍️0
      nonsequetor nonsequetor 2 years ago
      Since my call
      Jan 03, 2023 9:29 AM

      $DARE It has begun...

      DARE Since Post:
      $0.2566
      (30.07%)
      Then:$0.8534
      Now:$1.11

      UM...AH... looks like a winner already...
      and it has not even started!

      BUT...

      I really don't care what negativity others post. I have done my DD, bought low, and will ride the wave to prosperity.

      DARE is the real thing, with one of a kind, first in class products, that will turn many heads and make some (who do their own DD) wealthy.

      Good fortune to all (except shorts, who bet wrong on this leg up).
      👍️0
      harry crumb harry crumb 2 years ago
      Could be but highly unlikely this becomes a winner
      👍️0
      nonsequetor nonsequetor 2 years ago
      Just a little bit of DD will prove you wrong.
      👍️0
      harry crumb harry crumb 2 years ago
      Dont count on it, this team is not an has not proven anything yet. Could use new management for a change, the stock does note promote a very good company
      👍️0
      nonsequetor nonsequetor 2 years ago
      Hop aboard, this is just the beginning!
      👍️0
      nonsequetor nonsequetor 2 years ago
      DARE up over 30% already this year.
      👍️0
      nonsequetor nonsequetor 2 years ago
      Up 20% in 2 days
      👍️0
      nonsequetor nonsequetor 2 years ago
      UP 10% since yesterday morning.
      👍️0
      harry crumb harry crumb 2 years ago
      This pos needs to be shutdown, what a scam
      👍️0
      harry crumb harry crumb 2 years ago
      Some more news on dare
      👍️0
      nonsequetor nonsequetor 2 years ago
      Daré Bioscience Announces Subject Screening for Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder Complete

      https://finance.yahoo.com/news/dar-bioscience-announces-subject-screening-120000980.html
      👍️0
      harry crumb harry crumb 2 years ago
      Some news an this turd is stagnant, very boring company here
      👍️0
      harry crumb harry crumb 2 years ago
      Looks like this pos is going to its 3 yr low of .75 area. What junk!
      👍️0
      nonsequetor nonsequetor 2 years ago
      Q4 will be interesting
      👍️0
      nonsequetor nonsequetor 2 years ago
      WOW!! Nice EOD catapult!!
      👍️0
      nonsequetor nonsequetor 2 years ago
      Another week... another wait...

      ZZZZZZZZZZZZZZZZZZZZZZ
      👍️0
      MattSav MattSav 2 years ago
      Good looking week... Hope everyone is enjoying this move upwards... I know we are waiting on 4th quarter for real numbers but wondering if the sentiment here is good enough to through another 10k on shares lol
      👍️0
      nonsequetor nonsequetor 2 years ago
      YES!
      👍️0
      MattSav MattSav 2 years ago
      So should we be excited that they are doing Financials on a Tuesday?
      👍️0
      MattSav MattSav 2 years ago
      So is the corporate presentation today or what I can't open the damn thing
      👍️0
      nonsequetor nonsequetor 2 years ago
      https://www.sec.gov/Archives/edgar/data/0001401914/000149315222019342/ex3-1.htm
      👍️0
      MattSav MattSav 2 years ago
      Anyone find out how the vote went?
      👍️0
      kruy kruy 2 years ago
      You do realize that all the upfront payments and tiered royalties have to be split with the labs that actually invented and produce these products. DARE is only the middleman. These details are all spelled out in the last SEC annual filing.
      The best thing that could happen for us shareholders is that some big company that needs a pipeline will buy out this company and its entire complicated business model. Give me $5 a share and I'm happy. Reality wise, I think we could only get $3-$4 because they would need to come to agreements with all the labs that actually engineered all of the products. Either way, I'd be happy with any buyout because the business model as is could take a long time for DARE to break even or show a profit after splitting royalties with all parties involved.
      👍️0
      nonsequetor nonsequetor 2 years ago
      $$$$ Coming in from the Gates!
      https://ih.advfn.com/stock-market/NASDAQ/dare-bioscience-DARE/stock-news/88547783/current-report-filing-8-k
      👍️0
      nonsequetor nonsequetor 2 years ago
      This DARE stock will drive a sane man crazy!
      👍️0
      harry crumb harry crumb 2 years ago
      Employee stock incentive plan goes into effect with dare Bod approval. Always good news to have a employee purchase plan for company stock
      👍️0
      MattSav MattSav 2 years ago
      So im new to this stock... What are the opinions of the stock not getting its approval to increase shares?
      👍️0
      nonsequetor nonsequetor 2 years ago
      Just a few more days...
      👍️0
      nonsequetor nonsequetor 2 years ago
      CLINICAL TRIALS RESULTS JUST POSTED
      https://www.clinicaltrials.gov/ct2/show/results/NCT03598088?view=results
      👍️0

      Your Recent History

      NASDAQ
      DARE
      Dare Bioscience
      Delayed Upgrade Clock